AURA - Aura Biosciences reports Q4 results March, 23 2022 05:39 PM Aura Biosciences Inc. Aura Biosciences press release (NASDAQ:AURA): Q4 net loss of $11.6M As of December 31, 2021, company had cash and cash equivalents totaling $149.1M. For further details see: Aura Biosciences reports Q4 results